Copyright Reports & Markets. All rights reserved.

Global Medical Alpha Radionuclide Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Medical Alpha Radionuclide Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Actinium-225
    • 1.3.3 Astatine-211
    • 1.3.4 Lead-212
    • 1.3.5 Bismuth-213
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Medical Alpha Radionuclide Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Immunotherapy
    • 1.4.3 Peritoneal Carcinomas
    • 1.4.4 Bone Metastases
    • 1.4.5 Leukaemia
    • 1.4.6 Melanomas
    • 1.4.7 Solid Tumours
  • 1.5 Global Medical Alpha Radionuclide Market Size & Forecast
    • 1.5.1 Global Medical Alpha Radionuclide Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Medical Alpha Radionuclide Sales Quantity (2019-2030)
    • 1.5.3 Global Medical Alpha Radionuclide Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 ORNL
    • 2.1.1 ORNL Details
    • 2.1.2 ORNL Major Business
    • 2.1.3 ORNL Medical Alpha Radionuclide Product and Services
    • 2.1.4 ORNL Medical Alpha Radionuclide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 ORNL Recent Developments/Updates
  • 2.2 Tri-Lab
    • 2.2.1 Tri-Lab Details
    • 2.2.2 Tri-Lab Major Business
    • 2.2.3 Tri-Lab Medical Alpha Radionuclide Product and Services
    • 2.2.4 Tri-Lab Medical Alpha Radionuclide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Tri-Lab Recent Developments/Updates
  • 2.3 SSC RF-IPPE
    • 2.3.1 SSC RF-IPPE Details
    • 2.3.2 SSC RF-IPPE Major Business
    • 2.3.3 SSC RF-IPPE Medical Alpha Radionuclide Product and Services
    • 2.3.4 SSC RF-IPPE Medical Alpha Radionuclide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 SSC RF-IPPE Recent Developments/Updates
  • 2.4 JRC Karlsruhe
    • 2.4.1 JRC Karlsruhe Details
    • 2.4.2 JRC Karlsruhe Major Business
    • 2.4.3 JRC Karlsruhe Medical Alpha Radionuclide Product and Services
    • 2.4.4 JRC Karlsruhe Medical Alpha Radionuclide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 JRC Karlsruhe Recent Developments/Updates
  • 2.5 TerraPower
    • 2.5.1 TerraPower Details
    • 2.5.2 TerraPower Major Business
    • 2.5.3 TerraPower Medical Alpha Radionuclide Product and Services
    • 2.5.4 TerraPower Medical Alpha Radionuclide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 TerraPower Recent Developments/Updates
  • 2.6 TRIUMF
    • 2.6.1 TRIUMF Details
    • 2.6.2 TRIUMF Major Business
    • 2.6.3 TRIUMF Medical Alpha Radionuclide Product and Services
    • 2.6.4 TRIUMF Medical Alpha Radionuclide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 TRIUMF Recent Developments/Updates
  • 2.7 Eckert&Ziegler
    • 2.7.1 Eckert&Ziegler Details
    • 2.7.2 Eckert&Ziegler Major Business
    • 2.7.3 Eckert&Ziegler Medical Alpha Radionuclide Product and Services
    • 2.7.4 Eckert&Ziegler Medical Alpha Radionuclide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Eckert&Ziegler Recent Developments/Updates
  • 2.8 Ionetix
    • 2.8.1 Ionetix Details
    • 2.8.2 Ionetix Major Business
    • 2.8.3 Ionetix Medical Alpha Radionuclide Product and Services
    • 2.8.4 Ionetix Medical Alpha Radionuclide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Ionetix Recent Developments/Updates
  • 2.9 Orano Med
    • 2.9.1 Orano Med Details
    • 2.9.2 Orano Med Major Business
    • 2.9.3 Orano Med Medical Alpha Radionuclide Product and Services
    • 2.9.4 Orano Med Medical Alpha Radionuclide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Orano Med Recent Developments/Updates
  • 2.10 National Nuclear Laboratory
    • 2.10.1 National Nuclear Laboratory Details
    • 2.10.2 National Nuclear Laboratory Major Business
    • 2.10.3 National Nuclear Laboratory Medical Alpha Radionuclide Product and Services
    • 2.10.4 National Nuclear Laboratory Medical Alpha Radionuclide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 National Nuclear Laboratory Recent Developments/Updates
  • 2.11 NorthStar
    • 2.11.1 NorthStar Details
    • 2.11.2 NorthStar Major Business
    • 2.11.3 NorthStar Medical Alpha Radionuclide Product and Services
    • 2.11.4 NorthStar Medical Alpha Radionuclide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 NorthStar Recent Developments/Updates

3 Competitive Environment: Medical Alpha Radionuclide by Manufacturer

  • 3.1 Global Medical Alpha Radionuclide Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Medical Alpha Radionuclide Revenue by Manufacturer (2019-2024)
  • 3.3 Global Medical Alpha Radionuclide Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Medical Alpha Radionuclide by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Medical Alpha Radionuclide Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Medical Alpha Radionuclide Manufacturer Market Share in 2023
  • 3.5 Medical Alpha Radionuclide Market: Overall Company Footprint Analysis
    • 3.5.1 Medical Alpha Radionuclide Market: Region Footprint
    • 3.5.2 Medical Alpha Radionuclide Market: Company Product Type Footprint
    • 3.5.3 Medical Alpha Radionuclide Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Medical Alpha Radionuclide Market Size by Region
    • 4.1.1 Global Medical Alpha Radionuclide Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Medical Alpha Radionuclide Consumption Value by Region (2019-2030)
    • 4.1.3 Global Medical Alpha Radionuclide Average Price by Region (2019-2030)
  • 4.2 North America Medical Alpha Radionuclide Consumption Value (2019-2030)
  • 4.3 Europe Medical Alpha Radionuclide Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Medical Alpha Radionuclide Consumption Value (2019-2030)
  • 4.5 South America Medical Alpha Radionuclide Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Medical Alpha Radionuclide Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Medical Alpha Radionuclide Sales Quantity by Type (2019-2030)
  • 5.2 Global Medical Alpha Radionuclide Consumption Value by Type (2019-2030)
  • 5.3 Global Medical Alpha Radionuclide Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Medical Alpha Radionuclide Sales Quantity by Application (2019-2030)
  • 6.2 Global Medical Alpha Radionuclide Consumption Value by Application (2019-2030)
  • 6.3 Global Medical Alpha Radionuclide Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Medical Alpha Radionuclide Sales Quantity by Type (2019-2030)
  • 7.2 North America Medical Alpha Radionuclide Sales Quantity by Application (2019-2030)
  • 7.3 North America Medical Alpha Radionuclide Market Size by Country
    • 7.3.1 North America Medical Alpha Radionuclide Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Medical Alpha Radionuclide Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Medical Alpha Radionuclide Sales Quantity by Type (2019-2030)
  • 8.2 Europe Medical Alpha Radionuclide Sales Quantity by Application (2019-2030)
  • 8.3 Europe Medical Alpha Radionuclide Market Size by Country
    • 8.3.1 Europe Medical Alpha Radionuclide Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Medical Alpha Radionuclide Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Medical Alpha Radionuclide Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Medical Alpha Radionuclide Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Medical Alpha Radionuclide Market Size by Region
    • 9.3.1 Asia-Pacific Medical Alpha Radionuclide Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Medical Alpha Radionuclide Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Medical Alpha Radionuclide Sales Quantity by Type (2019-2030)
  • 10.2 South America Medical Alpha Radionuclide Sales Quantity by Application (2019-2030)
  • 10.3 South America Medical Alpha Radionuclide Market Size by Country
    • 10.3.1 South America Medical Alpha Radionuclide Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Medical Alpha Radionuclide Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Medical Alpha Radionuclide Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Medical Alpha Radionuclide Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Medical Alpha Radionuclide Market Size by Country
    • 11.3.1 Middle East & Africa Medical Alpha Radionuclide Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Medical Alpha Radionuclide Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Medical Alpha Radionuclide Market Drivers
  • 12.2 Medical Alpha Radionuclide Market Restraints
  • 12.3 Medical Alpha Radionuclide Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Medical Alpha Radionuclide and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Medical Alpha Radionuclide
  • 13.3 Medical Alpha Radionuclide Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Medical Alpha Radionuclide Typical Distributors
  • 14.3 Medical Alpha Radionuclide Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point.
    According to our (Global Info Research) latest study, the global Medical Alpha Radionuclide market size was valued at US$ 3376 million in 2023 and is forecast to a readjusted size of USD 8113 million by 2030 with a CAGR of 14.3% during review period.
    This report is a detailed and comprehensive analysis for global Medical Alpha Radionuclide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Medical Alpha Radionuclide market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2019-2030
    Global Medical Alpha Radionuclide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2019-2030
    Global Medical Alpha Radionuclide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2019-2030
    Global Medical Alpha Radionuclide market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/g), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Medical Alpha Radionuclide
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Medical Alpha Radionuclide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ORNL, Tri-Lab, SSC RF-IPPE, JRC Karlsruhe, TerraPower, TRIUMF, Eckert&Ziegler, Ionetix, Orano Med, National Nuclear Laboratory, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Medical Alpha Radionuclide market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Actinium-225
    Astatine-211
    Lead-212
    Bismuth-213
    Others
    Market segment by Application
    Immunotherapy
    Peritoneal Carcinomas
    Bone Metastases
    Leukaemia
    Melanomas
    Solid Tumours
    Major players covered
    ORNL
    Tri-Lab
    SSC RF-IPPE
    JRC Karlsruhe
    TerraPower
    TRIUMF
    Eckert&Ziegler
    Ionetix
    Orano Med
    National Nuclear Laboratory
    NorthStar
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Medical Alpha Radionuclide product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Medical Alpha Radionuclide, with price, sales quantity, revenue, and global market share of Medical Alpha Radionuclide from 2019 to 2024.
    Chapter 3, the Medical Alpha Radionuclide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Medical Alpha Radionuclide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Medical Alpha Radionuclide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Alpha Radionuclide.
    Chapter 14 and 15, to describe Medical Alpha Radionuclide sales channel, distributors, customers, research findings and conclusion.

    Buy now